ENDV

Endonovo Therapeutics, Inc.

USD

Set alert

Price alert · ENDV

All alert types
0.00 USD 0.00 0.00%
As of Oct 29, 2026
0.0001 Day range 0.0001
0.00005 52-week range 0.0002
YTD
-50.00%
1 year
-75.00%
Open
0.0001
Prev close
0.00005
Mkt cap
90.38K
Vol
500.00K
Avg vol
341.78K
EPS
0.00
P/E
0.00
More statistics
Low
0.0001
High
0.0001
Earnings
Feb 11, 2025

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ENDV has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-3199.61 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.1×
FY 2016: -1102×FY 2017: -1298×FY 2018: -1.0×FY 2019: -0.1×FY 2020: -0.6×FY 2021: -0.3×FY 2022: -0.1×FY 2023: 0.3×FY 2024: -0.1×FY 2025: -0.1×
FY 2016 5y median -0.1× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 79.2×FY 2019: 4.3×FY 2020: 1.5×FY 2021: 12.8×FY 2022: 18.5×FY 2023: 17.1×FY 2024: 21.7×FY 2025: 0.0×
FY 2016 5y median 17.1× FY 2025
P/B -0.0×
FY 2016: -0.7×FY 2017: -2.0×FY 2018: -0.6×FY 2019: -0.1×FY 2020: -0.0×FY 2021: -0.1×FY 2022: -0.1×FY 2023: -0.1×FY 2024: -0.0×FY 2025: -0.0×
FY 2016 5y median -0.1× FY 2025
P/FCF -2.6×
FY 2016: -2.4×FY 2017: -3.2×FY 2018: -2.3×FY 2019: -0.5×FY 2020: -0.3×FY 2021: -0.9×FY 2022: -3.7×FY 2023: 19.7×FY 2024: 2.2×FY 2025: -2.6×
FY 2016 5y median -0.9× FY 2025
EV/EBITDA -7.4×
FY 2016: -1.5×FY 2017: -5.2×FY 2018: -21.3×FY 2019: -0.8×FY 2020: 2.9×FY 2021: -5.3×FY 2022: -0.6×FY 2023: 1.1×FY 2024: -7.5×FY 2025: -7.4×
FY 2016 5y median -5.3× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 151×FY 2019: 26.3×FY 2020: 41.4×FY 2021: 110×FY 2022: 71.4×FY 2023: 67.6×FY 2024: 706×FY 2025: 0.0×
FY 2016 5y median 71.4× FY 2025
FCF Yield -39.2%
FY 2016: -42.0%FY 2017: -31.5%FY 2018: -43.8%FY 2019: -192.0%FY 2020: -302.0%FY 2021: -105.7%FY 2022: -27.1%FY 2023: 5.1%FY 2024: 46.2%FY 2025: -39.2%
FY 2016 5y median -27.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 84.5%FY 2019: 69.9%FY 2020: 60.6%FY 2021: 79.5%FY 2022: 92.6%FY 2023: -366.9%FY 2024: -6125.6%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -4995.3%FY 2019: -1228.1%FY 2020: -1756.5%FY 2021: -3045.7%FY 2022: -2411.7%FY 2023: -2081.7%FY 2024: -15532.5%FY 2025: 0.0%
FY 2016 5y median -2411.7% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -7729.5%FY 2019: -5582.4%FY 2020: -238.6%FY 2021: -4247.2%FY 2022: -13649.2%FY 2023: 4937.6%FY 2024: -27853.2%FY 2025: 0.0%
FY 2016 5y median -4247.2% FY 2025
ROE 7.5%
FY 2016: 62.1%FY 2017: 113.2%FY 2018: 56.5%FY 2019: 84.4%FY 2020: 2.8%FY 2021: 19.7%FY 2022: 57.4%FY 2023: -28.7%FY 2024: 10.4%FY 2025: 7.5%
FY 2016 5y median 10.4% FY 2025
ROIC 4.3%
FY 2016: 85.3%FY 2017: 113.3%FY 2018: 37.0%FY 2019: 32.6%FY 2020: 38.4%FY 2021: 26.2%FY 2022: 13.1%FY 2023: 17.2%FY 2024: 7.9%FY 2025: 4.3%
FY 2016 5y median 13.1% FY 2025
ROA -11275.3%
FY 2016: -1668.0%FY 2017: -234.4%FY 2018: -151.7%FY 2019: -528.7%FY 2020: -15.2%FY 2021: -154.7%FY 2022: -1441.9%FY 2023: 1082.5%FY 2024: -14502.0%FY 2025: -11275.3%
FY 2016 5y median -1441.9% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: -100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 272.5%FY 2020: -46.5%FY 2021: -55.9%FY 2022: 85.2%FY 2023: 3.6%FY 2024: -92.8%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income 39.4%
FY 2016: -116.6%FY 2017: 14.9%FY 2018: 9.7%FY 2019: 8.4%FY 2020: 23.5%FY 2021: 23.5%FY 2022: -46.6%FY 2023: 10.6%FY 2024: 46.6%FY 2025: 39.4%
FY 2016 FY 2025
EPS (diluted) 76.5%
FY 2016: 13.5%FY 2017: 1.3%FY 2018: -39631.5%FY 2019: -89.0%FY 2020: 99.9%FY 2021: -60.2%FY 2022: -150.5%FY 2023: 103.9%FY 2024: -200.0%FY 2025: 76.5%
FY 2016 FY 2025
Free Cash Flow -142.8%
FY 2016: -140.7%FY 2017: -143.3%FY 2018: 51.8%FY 2019: 11.9%FY 2020: 70.8%FY 2021: -33.0%FY 2022: 31.2%FY 2023: 118.0%FY 2024: -17.5%FY 2025: -142.8%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Debt / Equity -0.2×
FY 2016: -0.2×FY 2017: -0.5×FY 2018: -0.6×FY 2019: -0.3×FY 2020: -0.5×FY 2021: -0.5×FY 2022: -0.2×FY 2023: -0.3×FY 2024: -0.3×FY 2025: -0.2×
FY 2016 5y median -0.3× FY 2025
Net Debt / EBITDA -7.3×
FY 2016: -0.4×FY 2017: -1.0×FY 2018: -10.1×FY 2019: -0.6×FY 2020: 2.8×FY 2021: -4.7×FY 2022: -0.4×FY 2023: 0.8×FY 2024: -7.3×FY 2025: -7.3×
FY 2016 5y median -4.7× FY 2025
Interest Coverage -0.8×
FY 2016: -2.3×FY 2017: -0.8×FY 2018: -0.8×FY 2019: -0.6×FY 2020: -1.4×FY 2021: -2.4×FY 2022: -2.5×FY 2023: -2.3×FY 2024: -1.3×FY 2025: -0.8×
FY 2016 5y median -2.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31